Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy

Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy

Background and study aims: Current guidelines recommend using endoscopic ultrasound (EUS), carcinoembryonic antigen (CEA) testing and cytology to manage incidental pancreatic cystic neoplasms (PCN); however, studies suggest a strategy including integrated molecular pathology (IMP) of cyst fluid may...

Full description

Bibliographic Details
Main Authors: Ananya Das, William Brugge, Girish Mishra, Dennis M. Smith, Mankanwal Sachdev, Eric Ellsworth
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2015-06-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0034-1392016

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0034-1392016

Similar Items